Viscogliosi Brothers Acquisition, a blank check company targeting the North American and European neuro-musculoskeletal industry, filed on Thursday with the SEC to raise up to $75 million in an initial public offering.
The company plans to raise $75 million by offering 7.5 million units at $10. Each unit consists of one share of common stock and one-half of a warrant, exercisable at $11.50. At the proposed deal size, Viscogliosi Brothers Acquisition would command a market value of $94 million.
The SPAC is led by Chairman, President, and CEO John Viscogliosi, a founding member and Principal of single-family office Viscogliosi Bros and the former CEO of Centinel Spine, and CFO Steve Ward, the CFO and COO of Viscogliosi and former CFO of Paradigm Spine. Viscogliosi Brothers Acquisition plans to leverage management's experience and target the neuro-musculoskeletal (NMS) industry, specifically within the implantable devices, service, regenerative medicine, and contract manufacturing sectors.
The New York, NY-based company was founded in 2020 and plans to list on the Nasdaq under the symbol VBOC.U. Raymond James is the sole bookrunner on the deal.
